Asentral IRB Joins BRANY IRB (Biomedical Research Alliance of New York)

For Immediate Release
17 December 2019

Asentral, Inc. Institutional Review Board (IRB), based near the biotech hubs of Boston and Cambridge, Massachusetts, is joining BRANY, company officials announced today. BRANY will provide its full suite of IRB services to Asentral’s current clients.

“Asentral was founded by research professionals with deep research experience, and has been instrumental as a central IRB for sponsors for over 16 years,” said Raffaella Hart, Vice President, IRB and IBC Services at BRANY. “We are a natural fit with our cultures and dedication to human subject protection, as well as a delivering a high standard of service to clients.”

“We are thrilled to become part of the BRANY family,” said Asentral CEO Richard Clunie, who will remain on the team.  “In addition to BRANY’s expertise in IRB review, our clients will receive additional benefits, such as the use of IRBManager, an online tool for managing IRB submissions and accessing documents.”

This agreement reflects BRANY’s continued interest in providing the highest level of ethical IRB services to individual researchers, academic institutions, hospital systems, and industry sponsors, including medical device companies.


BRANY was founded over 21 years ago and is owned by four leading academic medical centers: Icahn School of Medicine at Mount Sinai, NYU School of Medicine, Montefiore Medical Center and Northwell Health. BRANY is a national company providing research support services including IRB/IBC review, clinical study support services, HRPP consulting and research compliance training.